Resultados de la búsqueda 171-180 of 16161 for https://bodemsanpham.com/

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  4. Salud de la mujer - Mayo Clinic

    https://www.cdc.gov/heartdisease/women.htm. Accessed Aug. 30, 2022. Key statistics for breast cancer. American Cancer Society. https://www.cancer.org/cancer ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.

  6. Mayo Clinic

    Share · Tweet . IMG-20451390. Inicio; cc-confident-woman-business_tablet. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.